Bank Of America Corp Bio Affinity Technologies, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 84 shares of BIAF stock, worth $67. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84
Previous 67
25.37%
Holding current value
$67
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BIAF
# of Institutions
16Shares Held
527KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$208,6950.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$79,6400.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC46.3KShares$37,0430.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$22,3080.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$14,0800.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $2.18M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...